This inventor holds 1 USPTO granted patent. Top assignee: Livercell L.l.c.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: F Saverio Ambesi-Impiombato: Innovator in Cell Culturing Methods
Introduction
F Saverio Ambesi-Impiombato is a notable inventor based in Udine, Italy. He has made significant contributions to the field of cell culturing, particularly focusing on human liver cells. His innovative methods have the potential to advance research and therapeutic applications in regenerative medicine.
Latest Patents
Ambesi-Impiombato holds a patent for a "Cell culturing method and medium." This invention outlines a comprehensive method for producing an expanded non-transformed cell culture of human liver cells. The process involves several steps, including preparing partially purified human liver tissue, concentrating the resulting cells, and resuspending them in a specialized growth medium. The method ensures that the cultured liver cells proliferate without transformation, resulting in a high-density cell suspension that can form organoids, mimicking the structure of the original organ.
Career Highlights
Ambesi-Impiombato's career is marked by his dedication to advancing cell culture techniques. His work has led to the development of methods that enhance the viability and functionality of human liver cells in culture. This innovation is crucial for various applications, including drug testing and disease modeling.
Collaborations
He has collaborated with notable colleagues in the field, including Francesco Curcio and Hayden G Coon. These partnerships have contributed to the refinement and application of his innovative methods in cell culturing.
Conclusion
F Saverio Ambesi-Impiombato's contributions to cell culturing represent a significant advancement in the field of regenerative medicine. His patented methods provide a foundation for future research and therapeutic developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile